Disc Col

Review Implications for managed care for improving outcomes in Parkinson's disease: balancing aggressive treatment with appropriate care.[Am J Manag Care. 2011]
Review Implications for managed care for improving outcomes in Parkinson's disease: balancing aggressive treatment with appropriate care.
Chen JJ. Am J Manag Care. 2011 Oct; 17 Suppl 12:S322-7.
Review Advanced strategies for treatment of Parkinson's disease: the role of early treatment.[Am J Manag Care. 2011]
Review Advanced strategies for treatment of Parkinson's disease: the role of early treatment.
Jann MW. Am J Manag Care. 2011 Oct; 17 Suppl 12:S315-21.
Review Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment.[Am J Manag Care. 2010]
Review Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment.
Chen JJ. Am J Manag Care. 2010 Mar; 16 Suppl Implications:S87-93.
Review Improving outcomes through early diagnosis of Parkinson's disease.[Am J Manag Care. 2012]
Review Improving outcomes through early diagnosis of Parkinson's disease.
Pagan FL. Am J Manag Care. 2012 Sep; 18(7 Suppl):S176-82.
Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia.[J Neurol Sci. 2012]
Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia.
Suh DC, Pahwa R, Mallya U. J Neurol Sci. 2012 Aug 15; 319(1-2):24-31. Epub 2012 Jun 2.

Review Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.[J Neurogastroenterol Motil. 2018]
Review Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.
Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G. J Neurogastroenterol Motil. 2018 Jan 30; 24(1):30-42.
metabolic profiling of Parkinson's disease and mild cognitive impairment.[Mov Disord. 2017]
metabolic profiling of Parkinson's disease and mild cognitive impairment.
Burté F, Houghton D, Lowes H, Pyle A, Nesbitt S, Yarnall A, Yu-Wai-Man P, Burn DJ, Santibanez-Koref M, Hudson G. Mov Disord. 2017 Jun; 32(6):927-932. Epub 2017 Apr 10.
The effects of a mindfulness-based lifestyle program for adults with Parkinson's disease: a mixed methods, wait list controlled randomised control study.[BMC Neurol. 2016]
The effects of a mindfulness-based lifestyle program for adults with Parkinson's disease: a mixed methods, wait list controlled randomised control study.
Advocat J, Enticott J, Vandenberg B, Hassed C, Hester J, Russell G. BMC Neurol. 2016 Sep 8; 16:166. Epub 2016 Sep 8.